This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Yong-Koo Kang: Innovator in Neurodegenerative Disease Treatment
Introduction
Yong-Koo Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patent developments. His work focuses on creating novel compounds that can aid in the prevention and treatment of various brain diseases.
Latest Patents
Yong-Koo Kang holds a patent for "Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same." This patent introduces novel benzoarylureido compounds that are designed for the prevention and treatment of neurodegenerative brain diseases, including Alzheimer's disease, dementia, Parkinson's disease, and others. His research aims to provide new therapeutic options for these debilitating conditions.
Career Highlights
Kang is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential impact on public health, particularly in addressing the challenges posed by neurodegenerative diseases. With 1 patent to his name, he continues to push the boundaries of scientific innovation.
Collaborations
Yong-Koo Kang has collaborated with notable colleagues, including Hoh-Gyu Hahn and Kee-Dal Nam. These partnerships have enhanced his research efforts and contributed to the advancement of knowledge in the field of neurodegenerative disease treatment.
Conclusion
Yong-Koo Kang is a dedicated inventor whose work in neurodegenerative disease treatment holds promise for improving the lives of many. His innovative compounds and research efforts are paving the way for new therapeutic strategies in combating these challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
